|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Total net loss | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Amortization of debt issuance costs – related party | |||||
| Issuance of warrants for consulting services | |||||
| Fair value of vested incentive stock options | |||||
| Discount on related party note payable | |||||
| Issuance of common stock for consulting services | |||||
| Impairment expense | |||||
| Stock-based compensation | |||||
| Amortization of debt discount | |||||
| Change in fair value of derivative liability | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Related party receivables | |||||
| Accounts payable and accrued expenses | |||||
| Accrued expenses - related party | |||||
| Players balances | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Cash paid for capitalized software | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from line of credit, related party | |||||
| Proceeds from convertible notes | |||||
| Repayments of convertible note | |||||
| Net cash provided by financing activities | |||||
| NET CHANGE IN CASH AND CASH RESERVED FOR USERS | |||||
| CASH AND CASH RESERVED FOR USERS AT BEGINNING OF PERIOD | |||||
| CASH AND CASH RESERVED FOR USERS AT END OF PERIOD | |||||
| DISCLOSURE OF CASH AND CASH RESERVED FOR USERS: | |||||
| CASH | |||||
| CASH RESERVED FOR USERS | |||||
| SUPPLEMENTAL INFORMATION: | |||||
| Interest paid | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES: | |||||
| Derivative liability associated with convertible note issuance | |||||
| Common stock and warrants issued for offering costs | |||||
| Insurance financing | |||||
| Payoff of related party note payable with related party line of credit | |||||
| Common stock issued upon conversion of debt | |||||
| Derivative and warrants issued for deferred financing costs | |||||
| Note receivable received in common-control transaction | |||||
| Related-party receivable settled in common-control transaction | |||||
| Additional Paid-In Capital recognized in association with common control transaction | |||||
Loading...